SLC7A11 and Stroke: It reduced high iron levels demonstrated in the stroke model. It also decreased lipid peroxidation with lower levels of malondialdehyde. It increased the levels of GSH and the expression of SLC7A11 and GPX 4. It reduced the infarct size and improved the neurobehavioral outcomes.